AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.

Quotes for AcouSort AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Torsten Freltoft

Chairperson of the Board

  • Martin Linde

Board

  • Kristian Enkvist
  • Stefan Scheding
  • Thomas Laurell

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 9,48 9,48 2024-09-26
Thomas Laurell 7,35 7,35 2024-09-26
Stefan Scheding 6,08 6,08 2024-09-26
Torsten Freltoft 5,93 5,93 2024-09-26
Nordnet Pensionsförsäkring 3,06 3,06 2024-09-26
Svenska Handelsbanken AB for PB 2,95 2,95 2024-09-26
Johan Nilsson 2,12 2,12 2024-09-26
Per Lundin 1,67 1,67 2024-09-26
Lars Svensson 1,58 1,58 2024-09-26
Dennis Björnlund Johansen 1,47 1,47 2024-09-26